I found this posted at BIZ.YAHOO.COM on Wednesday.

"WHITEHOUSE STATION, N.J.----Merck today announced a non-exclusive license agreement with Laboratory Corporation of America? Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy."